Disseminated BCG Infection and Primary Immunodeficiencies: A Report from Two Tertiary Centers

Background: One of the most serious complications of BCG immunization is disseminated BCG infection, which is suggested to occur in immunized children with underlying primary immunodeficiencies. Objectives: This study aimed to assess the clinical manifestations and underlying primary immunodeficiencies associated with disseminated BCG infection. Methods: The study enrolled 47 patients suspected of disseminated BCG infection referring to Mofid Children Hospital and Masih Daneshvari Hospital for 12 years. The patients’ records were reviewed and patients were classified into three distinctive groups of definitive, probable, or possible disseminated BCG infection. Results: Twenty-five(53.2%)patientsweremaleandtwenty-two(46.8%)werefemale. Themeanageatonsetof clinicalmanifestations was 4.83 months. The first presentation of the disease occurred within one year of vaccination in 28 (60%) patients. Clinical mani-festationsincludedlymphadenopathies(61%),fever(38%),hepatosplenomegaly(36%),failuretothrive(23%),skinrash(14%),chronic cough (10%), ascites (6%), and clubbing (6%). The confirmed underlying primary immunodeficiency detected in these patients were Mendelian Susceptibility to Mycobacterial Disease (MSMD; 69.56%), Severe Combined Immunodeficiency (SCID; 26%) and Chronic Granulomatous Disease (CGD; 4.3%). Conclusions: Disseminated BCG infection may be a devastating complication and an important preliminary manifestation of un-derlyingprimaryimmunodeficiency. Becauseofthewidespectrumofmortalityandmorbidity,aswellasthesocioeconomicburden on the health system, it is worth to take a careful medical history before BCG immunization particularly in families with a history of consanguineous marriage and death due to unknown etiology.

[1]  A. Alrabiaah,et al.  Disseminated bacille Calmette-Guérin disease in Saudi children: clinical profile, microbiology, immunology evaluation and outcome. , 2016, European review for medical and pharmacological sciences.

[2]  A. Velayati Tuberculosis in children , 2016, International journal of mycobacteriology.

[3]  Amitabh Singh,et al.  Disseminated BCG Disease in an Infant with Severe Combined Immunodeficiency , 2016 .

[4]  B. Geramizadeh,et al.  Post-Vaccination Disseminated Bacillus Calmette Guerin Infection Among Children in Southern Iran , 2015, Jundishapur journal of microbiology.

[5]  M. Alshehri,et al.  Bacillus Calmette–Guérin vaccine related lymphadenitis in children: Management guidelines endorsed by the Saudi Pediatric Infectious Diseases Society (SPIDS) , 2015, International journal of pediatrics & adolescent medicine.

[6]  Z. Memish,et al.  Molecular Confirmation of Bacillus Calmette Guerin Vaccine Related Adverse Events among Saudi Arabian Children , 2014, PloS one.

[7]  Jinqiao Sun,et al.  Clinical Characteristics and Immunogenetics of BCGosis/BCGitis in Chinese Children: A 6 Year Follow-Up Study , 2014, PloS one.

[8]  O. Parkash How to avoid the impact of environmental mycobacteria towards the efficacy of BCG vaccination against tuberculosis? , 2014, International journal of mycobacteriology.

[9]  J. Black,et al.  Mycotic aortic aneurysm due to intravesical BCG immunotherapy: Clinical manifestations and diagnostic challenges. , 2014, International journal of mycobacteriology.

[10]  M. S. Rezai,et al.  BCG-osis after BCG vaccination in immunocompromised children: Case series and review , 2014 .

[11]  E. Goudouris,et al.  Severe combined immunodeficiency in Brazil: management, prognosis, and BCG-associated complications. , 2014, Journal of investigational allergology & clinical immunology.

[12]  A. McLellan,et al.  Extracellular forms of Mycobacterium bovis BCG in the mucosal lymphatic tissues following oral vaccination. , 2013, International journal of mycobacteriology.

[13]  S. Rosenzweig,et al.  Bacillus Calmette-Guérin (BCG) complications associated with primary immunodeficiency diseases. , 2012, The Journal of infection.

[14]  S. Papanicolaou,et al.  Cost-effectiveness of 13-valent pneumococcal conjugate vaccine: Germany, Greece, and The Netherlands. , 2012, The Journal of infection.

[15]  N. Rezaei,et al.  Disseminated bacille Calmette-Guérin in Iranian children with severe combined immunodeficiency. , 2009, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[16]  M. S. Rezai,et al.  Disseminated Bacillus Calmette-Guerin infection after BCG vaccination. , 2008, Journal of tropical pediatrics.

[17]  P. Rosenthal,et al.  Pattern of malaria-specific T-cell responses in a cohort of Ugandan children. , 2007, Journal of tropical pediatrics.

[18]  J. Casanova,et al.  Disseminated Bacillus Calmette-Guérin Infection and Immunodeficiency , 2007, Emerging infectious diseases.

[19]  Noorbakhsh Samileh,et al.  Type of Immunodeficiency, Treatment and Outcomes of Serious BCG Vaccine Complications: A 15 Year Survey , 2007 .

[20]  S. Mamishi,et al.  Disseminated Mycobacterium bovis infection after BCG vaccination. , 2006, Iranian journal of allergy, asthma, and immunology.

[21]  Grange Jm,et al.  Complications of bacille Calmette-Guérin (BCG) vaccination and immunotherapy and their management. , 1998, Communicable disease and public health.

[22]  A. Fischer,et al.  Immunological conditions of children with BCG disseminated infection , 1995, The Lancet.